Green Cross Health (NZSE:GXH) Is Paying Out A Dividend Of NZ$0.0412
Nov 28
New Zealand (NZX) Drug Retail Industry Analysis
UpdatedJan 26, 2023
DataAggregated Company Financials
Companies1
- 7D-0.7%
- 3M7.2%
- 1Y12.6%
- YTD-1.5%
In the last week, Drug Retail has been flat. The past year has been better, since the industry has gained 13% in that time.
Industry Valuation and Performance
Has the New Zealand Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 26 Jan 2023 | NZ$192.0m | NZ$715.5m | NZ$26.3m | 7.3x | 7.3x | 0.3x |
| Sat, 24 Dec 2022 | NZ$192.0m | NZ$715.5m | NZ$26.3m | 7.3x | 7.3x | 0.3x |
| Mon, 21 Nov 2022 | NZ$171.9m | NZ$670.3m | NZ$24.6m | 7x | 7x | 0.3x |
| Wed, 19 Oct 2022 | NZ$186.3m | NZ$670.3m | NZ$24.6m | 7.6x | 7.6x | 0.3x |
| Fri, 16 Sep 2022 | NZ$192.0m | NZ$670.3m | NZ$24.6m | 7.8x | 7.8x | 0.3x |
| Sun, 14 Aug 2022 | NZ$197.7m | NZ$670.3m | NZ$24.6m | 8.1x | 8.1x | 0.3x |
| Tue, 12 Jul 2022 | NZ$190.6m | NZ$670.3m | NZ$24.6m | 7.8x | 7.8x | 0.3x |
| Thu, 09 Jun 2022 | NZ$191.8m | NZ$670.3m | NZ$24.6m | 7.8x | 7.8x | 0.3x |
| Sat, 07 May 2022 | NZ$193.3m | NZ$603.2m | NZ$17.6m | 11x | 11x | 0.3x |
| Mon, 04 Apr 2022 | NZ$189.0m | NZ$603.2m | NZ$17.6m | 10.8x | 10.8x | 0.3x |
| Wed, 02 Mar 2022 | NZ$173.2m | NZ$603.2m | NZ$17.6m | 9.9x | 9.9x | 0.3x |
| Fri, 28 Jan 2022 | NZ$170.4m | NZ$603.2m | NZ$17.6m | n/a | 9.7x | 0.3x |
| Sun, 26 Dec 2021 | NZ$163.2m | NZ$603.2m | NZ$17.6m | 9.3x | 9.3x | 0.3x |
| Tue, 23 Nov 2021 | NZ$166.1m | NZ$570.4m | NZ$16.8m | n/a | 9.9x | 0.3x |
| Thu, 21 Oct 2021 | NZ$180.4m | NZ$570.4m | NZ$16.8m | 10.8x | 10.8x | 0.3x |
| Sat, 18 Sep 2021 | NZ$166.1m | NZ$570.4m | NZ$16.8m | 9.9x | 9.9x | 0.3x |
| Mon, 16 Aug 2021 | NZ$164.6m | NZ$570.4m | NZ$16.8m | 9.8x | 9.8x | 0.3x |
| Mon, 31 May 2021 | NZ$153.2m | NZ$570.4m | NZ$16.8m | 9.1x | 9.1x | 0.3x |
| Thu, 04 Mar 2021 | NZ$150.3m | NZ$570.3m | NZ$16.0m | 9.4x | 9.4x | 0.3x |
| Sun, 06 Dec 2020 | NZ$148.9m | NZ$570.3m | NZ$15.3m | 9.7x | 9.7x | 0.3x |
| Wed, 09 Sep 2020 | NZ$147.4m | NZ$569.4m | NZ$14.4m | 10.2x | 10.2x | 0.3x |
| Tue, 02 Jun 2020 | NZ$147.4m | NZ$568.5m | NZ$13.5m | 10.9x | 10.9x | 0.3x |
| Fri, 06 Mar 2020 | NZ$161.8m | NZ$564.4m | NZ$14.2m | 11.4x | 11.4x | 0.3x |
Price to Earnings Ratio
13.2x
Current Industry PE
- There is only one company in the New Zealander Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have grown 23% per year over the last three years.
- Revenues for these companies have grown 8.2% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does New Zealand Drug Retail compare with similar industries?
| NZ Market | 0.68% | |
| Consumer Staples | -1.56% | |
| Food and Staples Retail | -1.37% | |
| Drug Retail | -0.74% | |
| Food Distributors | 9.72% | |
| Big Box Super Stores | 0% | |
| Food Retail | -5.00% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GXH Green Cross Health | NZ$1.39 | 6.1% +NZ$11.5m | 17.8% | PE7.6x |